{"schema_version":"secwatch.filing_event.v1","accession":"0001022079-24-000153","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2024-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.911722+00:00","generated_at":"2026-05-31T17:45:49.671114+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Quest Diagnostics beats Q2 estimates, raises full-year guidance; announces four acquisitions","bullets":["Q2 revenues $2.397B (+2.5% YoY); reported EPS $2.03 (-1% YoY), adjusted EPS $2.35 (+2.2% YoY)","Full-year 2024 revenue guidance raised to $9.50-9.58B; adjusted EPS raised to $8.80-9.00","Announces four acquisitions: LifeLabs (pending), Allina Health, OhioHealth outreach labs, PathAI Diagnostics (completed)","Base business revenue growth ~4%; driven by new customers, advanced diagnostics, healthcare utilization","Cash from ops guided ~$1.3B; capex ~$420M; both unchanged from prior guidance"],"urls":{"canonical":"https://secwatch.observer/filing/0001022079-24-000153","json":"https://secwatch.observer/filing/0001022079-24-000153.json","markdown":"https://secwatch.observer/filing/0001022079-24-000153.md","text":"https://secwatch.observer/filing/0001022079-24-000153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000102207924000153/0001022079-24-000153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000102207924000153/dgx-20240723.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T17:45:49.671114+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}